Landscape of guidance documents used at TropNet and GeoSentinel centres for the clinical management of schistosomiasis outside endemic areas: A systematic appraisal.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tamarozzi Francesca, Mazzi Cristina, Antinori Spinello, Arsuaga Marta, Becker Sören L, Bocanegra Cristina, Bottieau Emmanuel, Buonfrate Dora, Bustinduy Amaya L, Camprubí-Ferrer Daniel, Caumes Eric, Duvignaud Alexandre, Grobusch Martin P, Huits Ralph, Jaureguiberry Stephane, Jordan Sabine, Mueller Andreas, Ndao Momar, Neumayr Andreas, Perez-Molina Jose A, Pettersen Frank O, Rothe Camilla, Salas-Coronas Joaquin, Salvador Fernando, Stothard J Russell, Tomasoni Lina R, van Hellemond Jaap J, van Lieshout Lisette, Vaughan Stephen D, Wammes Linda J, Yansouni Cedric P, Zammarchi Lorenzo, Gobbi Federico G
Аннотация
METHODS: We systematically appraised the following data from the referenced guidance documents: i) document type, ii) case definitions, iii) diagnostic techniques envisaged; iv) treatment recommendations; v) follow-up recommendations; vi) screening recommendations, and vii) symptom-based diagnostic suspicion.
RESULTS: Twenty-two of the 30 responders (73.3 %) indicated 19 reference documents, three of which were WHO material not intended for individual clinical management. Only 4/19 (21.1 %) documents were national recommendations; no international guideline was indicated. Case definitions were explicitly presented in only one document (1/19; 5.3 %). Diagnostic tools were detailed in 11/16 (68.8 %) and follow-up guidance in 8/16 (50 %) documents. Treatment guidance was provided in 14/16 (87.5 %) documents.
CONCLUSIONS: Heterogeneity in clinical guidance was evident, although with noticeable overlap at least for chronic schistosomiasis. This confirms the need to formalise case definitions, which should be used to design trials to rigorously assess diagnostic tools and treatment schemes, and eventually come to harmonization of clinical management guidance.